SARS-CoV-2 neutralizing antibody bebtelovimab - a systematic scoping review and meta-analysis
Description
CONCLUSION: Preclinical evidence suggests bebtelovimab be a potential treatment for COVID-19 amidst viral evolution. Bebtelovimab has comparable efficacy to other COVID-19 therapies without evident safety concerns.
